It was a red-letter day in October 2015 when the Food and Drug Administration (FDA) approved the first female sexual enhancement medication for marketing in the U.S. The so-called female Viagra, sold under the brand name Addyi, had been rejected twice in the five years prior over doubts about its effectiveness and concerns of potential side effects. When it finally hit the market, expectations were high. A year later, Valeant Pharmaceuticals International Inc., which acquired the female libido pill from Sprout Pharmaceuticals Inc. in a $1 billion buyout last year, was slapped with a lawsuit by former Sprout investors. The lawsuit ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.